DO YOU KNOW YOUR EMPLOYEE'S RISK UP AGAINST
COVID-19?

PROTECT YOUR COMPANY BASED ON DATA OBTAINED BY MOLECULAR MEDICINE

reliability

0 %
Download here all the information about
NECENTI-COV19

SHOULD MY FINANCIAL DIRECTOR ATTEND MEETINGS IN PERSON OR ONLINE?

WHICH OF MY AGENTS WILL BE ASYMPTOMATIC IF INFECTED BY THE VIRUS?

WHO ON MY COMMERCIAL TEAM WOULD HAVE TO BE TREATED IN THE ICU?

Which employees should be vaccinated against the virus as a priority?

Our technology, NECENTI-COV19™, allows you
answer these questions based on
three fundamental pillars:

YOUR EMPLOYEE´S RISK OF CONTAGION WHEN EXPOSED TO THE VIRUS.

THE SYMPTOM SEVERITY THAT THEY WOULD FACE IN THE CASE OF INFECTION.

THE PRIORITY OF VACCINATION TO BE ASSIGNED TO EACH ONE

Screenshot of the NECENTI100™ Platform

YOU WILL ONLY HAVE TO COMPLETE THIS PROCESS ONCE

WE TRAVEL TO YOUR INSTALLATIONS

In our specially prepared vehicles, we extract employee´s blood samples and ask them to complete a brief questionnaire, doing so in shifts so as not to interrupt your work flow.

WE CONDUCT A MOLECULAR ANALYSIS OF SAMPLES

In our private laboratories, using our own technology which is exclusive throughout Europe.

WE PREPARE A PERSONALIZED RISK REPORT

of COVID19 for the workers of your company, including vaccination date, ideal for everyone, considering the dosage available within your region.

DAVID OAKLEY

Sales Director (UNITED KINGDOM)

If infected: his symptoms would require hospitalization. Recovery period estimated at 3 or more weeks.
Contagion risk: low probability.
Suggested vaccination date: September 15, 2021.

NADINE AUBRIOT

Financial Director (BELGIUM)

If infected: her symptoms would require immediate admission to the ICU. Estimated recovery time between 4 and 8 weeks.
Contagion risk: high probability.
Suggested vaccination date: April 10, 2021.

EDUARDO JIMÉNEZ

Production operator on cosmetic supply chain (SPAIN)

If infected:he would be asymptomatic, and would not require a recovery period. However, he could still unknowingly spread the virus to coworkers.
Contagion risk: high probability.
Suggested vaccination date: May 3, 2021.

NASHA SILVERMAN

In-person customer service in a telecommunications shop (USA)

If infected: If infected: her symptoms would be mild, similar to a flu. Recovery time between 5 and 15 days.
Contagion risk: low probability.
Suggested vaccination date: October 14, 2021.

Our technology: the NECENTI100™ Platform to fight COVID-19

For a disease to occur in the human body, there are two factors that need to interact: the genome (also known as DNA, which is inherited and determines only up to 20% of disease development), and epigenetics (which is defined by our surroundings and carries up to 80% of influence in the development of a given illness). Ultimately, epigenetics decides which genes are activated and which are not, making it a key factor in the progression of or protection against illness, given that it is modifiable through specific and personalized changes for each individual. Using biochemical algorithms that measure epigenetic signatures, the biotechnology platform Necenti100™ is able to get an average of 10 years ahead of disease, and precisely measure the severity of its effects on the patient if/when they begin to develop symptoms. Moreover, it offers personalized solutions to mitigate and even prevent said disease. 

In the case of COVID-19, this disease is 100% epigenetic: in order for a person to become infected, there needs to be certain epigenetic surroundings and a given molecular context present. 

Using our Necenti100™ technology, which is based on research we have carried out over the last 10 years, we have identified various epigenetic biomarkers at the molecular level that determine what the evolution and symptom severity will look like in cases of infection, as well as the degree of risk that each person has of becoming infected. All of this is done with over 96% reliability, and all before the actual infection occurs.